[68Ga]DOTATOC PET-derived radiomics to predict genetic background of head and neck paragangliomas: a pilot investigation Miriam PepponiValentina BertiAlessio Imperiale Original Article 30 April 2024
Nuclear medicine practice for the assessment of cardiac sarcoidosis and amyloidosis. A survey endorsed by the EANM and EACVI. Irene GotuzzoRiemer H.J.A. SlartPaola A. Erba Editorial 29 April 2024 Pages: 1809 - 1815
Development and first-in-human study of PSMA-targeted PET tracers with improved pharmacokinetic properties Haodong HouYuan PanFeng Gao Original Article 29 April 2024
Can current preclinical strategies for radiopharmaceutical development meet the needs of targeted alpha therapy? Janke KleynhansThomas EbenhanMike Machaba Sathekge Review Article Open access 27 April 2024 Pages: 1965 - 1980
Validation of cardiac image-derived input functions for functional PET quantification Murray Bruce ReedPatricia Anna HandschuhAndreas Hahn Original Article Open access 27 April 2024
EANM consensus document on the use of [18F]FDG PET/CT in fever and inflammation of unknown origin Søren HessEdel Noriega-ÁlvarezOlivier Gheysens Original Article Open access 27 April 2024
Correction to: Highlights of the 36th EANM Annual Congress 2023, from hometown Vienna, Austria: “A SYMPHONY OF SCIENCE” David KerstingSilvia MorbelliHein J. Verberne Correction Open access 25 April 2024 Pages: 2159 - 2159
Comparison of novel PSMA-targeting [177Lu]Lu-P17-087 with its albumin binding derivative [177Lu]Lu-P17-088 in metastatic castration-resistant prostate cancer patients: a first-in-human study Linlin LiJiarou WangZhaohui Zhu Original Article 25 April 2024
Letter to the editor concerning “Cardiac [99mTc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis: an early follow-up marker?” An-Li YuCheng-Hsuan TsaiYen-Hung Lin Letter to the Editor 24 April 2024
How nuclear imaging changed parathyroid surgical strategies through time H. M. SchouwM. E. NoltesS. Kruijff Editorial 23 April 2024
Enhancing surgical outcomes: accurate identification and removal of prostate cancer with B7-H3-targeted NIR-II molecular imaging Yaqi TianHongliang ShenJie Tian Original Article 22 April 2024
Synthesis and preclinical evaluation of novel 18F-vancomycin-based tracers for the detection of bacterial infections using positron emission tomography G. B. SpoelstraS. N. BlokP. H. Elsinga Original Article Open access 22 April 2024
Combined, yet separate: cocktails of carriers (not drugs) for actinium-225 α-particle therapy of solid tumors expressing moderate-to-low levels of targetable markers Rajiv Ranjit NairAprameya PrasadStavroula Sofou Original Article 20 April 2024
The role of [18 F]FDOPA PET as an adjunct to conventional MRI in the diagnosis of aggressive glial lesions Adeline ZinszCelso PougetAntoine Verger Original Article 19 April 2024
B-Glycine as a marker for β cell imaging and β cell mass evaluation Yuxiang HanHui LiuZhibo Liu Original Article 18 April 2024
Same-day post-therapy imaging with a new generation whole-body digital SPECT/CT in assessing treatment response to [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer Hong SongMaria Isabel LeonioAndrei Iagaru Original Article 18 April 2024
Cadherin-17 as a target for the immunoPET of adenocarcinoma Samantha DelaneyOuti KeinänenBrian M. Zeglis Original Article Open access 16 April 2024
Intraoperative image-guidance during robotic surgery: is there clinical evidence of enhanced patient outcomes? Stefano TapperoGiuseppe FallaraPaolo Dell’Oglio Review Article 12 April 2024
Visual extended reality tools in image-guided surgery in urology: a systematic review Enrico CheccucciAlberto PianaFrancesco Porpiglia Review Article 09 April 2024
Artificial intelligence-based application in multiple myeloma Leandra PiscopoMariano ScaglioneMichele Klain Editorial 08 April 2024 Pages: 1923 - 1925
PET/CT study of dopamine transporter (DAT) binding with the triple reuptake inhibitor toludesvenlafaxine in rats and humans Zhiwei HuangJunhao WuYifeng Shen Original Article 08 April 2024
Clinicopathological and molecular predictors of [18F]FDG-PET disease detection in HER2-positive early breast cancer: RESPONSE, a substudy of the randomized PHERGain trial Antonio Llombart-CussacAleix PratGeraldine Gebhart Original Article Open access 08 April 2024
Targeting CXCR4/CXCL12 axis via [177Lu]Lu-DOTAGA.(SA.FAPi)2 with CXCR4 antagonist in triple-negative breast cancer Guangfa BaoZiqiang WangXiaohua Zhu Original Article Open access 08 April 2024
An ultra-small organic dye nanocluster for enhancing NIR-II imaging-guided surgery outcomes Yajun WangDing ZhouShoujun Zhu Original Article 06 April 2024
Highlights of the 36th EANM Annual Congress 2023, from hometown Vienna, Austria: “A SYMPHONY OF SCIENCE” David KerstingSilvia MorbelliHein J. Verberne Editorial 04 April 2024 Pages: 1800 - 1808
Optimizing the pharmacokinetics of an 211At-labeled RGD peptide with an albumin-binding moiety via the administration of an albumin-binding inhibitor Hiroaki EchigoMasayuki MunekaneKazuma Ogawa Original Article Open access 04 April 2024
Latent phosphaturic mesenchymal tumor in left planta detected by [18F]F-AlF-NOTA-octreotide PET/CT Congcong YuLin ChenHong Zhang Image of the Month 03 April 2024
Targeted interleukin-2 enhances the in vivo anti-cancer activity of Pluvicto™ Tony GeorgievLucrezia PrincipiSamuele Cazzamalli Short Communication 02 April 2024
Initial [18F]DCFPyL PET/CT in treatment-naïve prostate cancer: correlation with post-ADT PSA outcomes and recurrence Yuekai LiShiwei WangXiang Li Short Communication 02 April 2024
The status of nuclear medicine in China: the first official national survey Haiqiong ZhangJin ZhengLi Huo Original Article 02 April 2024
Disrupted gut microecology after high-dose 131I therapy and radioprotective effects of arachidonic acid supplementation Ganghua LuDingwei GaoZhongwei Lv Original Article Open access 02 April 2024
Clinical translation of a novel FAPI dimer [68Ga]Ga-LNC1013 Yue TanJian LiJingjing Zhang Original Article 02 April 2024
The effect of prednisolone and a short-term prednisolone discontinuation for the diagnostic accuracy of FDG-PET/CT in polymyalgia rheumatica—a prospective study of 101 patients Andreas Wiggers NielsenIb Tønder HansenKresten Krarup Keller Original Article Open access 02 April 2024
Macrophage mannose receptor CD206 targeting of fluoride-18 labeled mannosylated dextran: A validation study in mice Putri AndrianaRuth Fair-MäkeläAnne Roivainen Original Article Open access 27 March 2024
Diagnostic imaging of the diabetic foot: an EANM evidence-based guidance Chiara LauriEdel Noriega-ÁlvarezAlberto Signore Original Article Open access 27 March 2024
Dosimetry and pharmacokinetics of [177Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumours Seval Beykan SchürrleUta EberleinMichael Lassmann Original Article Open access 26 March 2024
Whole-body tumour burden on [18F]DCFPyL PET/CT in biochemical recurrence of prostate cancer: association with tumour biology and PSA kinetics Laura García-ZoghbyMariano Amo-SalasAna María García Vicente Original Article 23 March 2024
Correction to: A bis-boron boramino acid PET tracer for brain tumor diagnosis Zhu LiJunyi ChenZhibo Liu Correction 22 March 2024 Pages: 1796 - 1797
The superior detection rate of total-body [68Ga]Ga-PSMA-11 PET/CT compared to short axial field-of-view [68Ga]Ga-PSMA-11 PET/CT for early recurrent prostate cancer patients with PSA < 0.2 ng/mL after radical prostatectomy Yining WangLiang DongRuohua Chen Original Article 22 March 2024
A rationally designed nuclei-targeting FAPI 04-based molecular probe with enhanced tumor uptake for PET/CT and fluorescence imaging Xingyang ZhaoGuojin ZhangLiming Nie Original Article 21 March 2024 Pages: 1593 - 1604
Image-based dosimetry for [225Ac]Ac-PSMA-I&T therapy and the effect of daughter-specific pharmacokinetics Grigory LiubchenkoGuido BöningAstrid Delker Original Article Open access 21 March 2024
“Metabolic fingerprints” of cachexia in lung cancer patients Armin FrilleJann Arends(the LuCaPET consortium) Letter to the Editor Open access 20 March 2024 Pages: 2067 - 2069
Near-infrared II theranostic agents for the diagnosis and treatment of Alzheimer’s disease Can ZhouFantian ZengJian Yang Review Article 19 March 2024
Challenges coexist with opportunities: development of a macrocyclic peptide PET radioligand for PD-L1 Wenpeng HuangMai Hong SonWeibo Cai Editorial 16 March 2024 Pages: 1574 - 1577
Non-invasive assessment of stimulation-specific changes in cerebral glucose metabolism with functional PET Godber Mathis GodbersenPia FalbAndreas Hahn Original Article Open access 16 March 2024
Early detection of anthracycline-induced cardiotoxicity using [68 Ga]Ga-FAPI-04 imaging Zhuxin WeiHongchuang XuShihua Zhao Original Article 16 March 2024
Radiofrequency ablation versus radioactive iodine: the race for the best cure Fabio VolpeCarmela NappiMichele Klain Editorial 15 March 2024 Pages: 2047 - 2049
Diagnostic and prognostic value of dual-point amyloid PET in Alzheimer’s disease (AD) mimickers Luca SofiaFederico MassaSilvia Morbelli Image of the Month Open access 14 March 2024
ImmunoPET/CT imaging of clear cell renal cell carcinoma with [18F]RCCB6: a first-in-human study Qianyun WuYanfei WuWeijun Wei Original Article 14 March 2024
[177Lu]Lu-PSMA-617 as first-line systemic therapy in patients with metastatic castration-resistant prostate cancer: a real-world study Swayamjeet SatapathyMadhav Prasad YadavChandrasekhar Bal Original Article 12 March 2024
